Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) has issued an announcement.
Shanghai Bio-Heart Biological Technology Co., Ltd. has announced the composition of its board of directors and their respective roles within the company. This announcement provides clarity on the governance structure, which is crucial for stakeholders to understand the leadership dynamics and decision-making processes within the company.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-Heart Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development of innovative biological solutions. The company is incorporated in the People’s Republic of China and is publicly traded under the stock code 2185.
YTD Price Performance: 82.32%
Average Trading Volume: 324,494
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.25B
Learn more about 2185 stock on TipRanks’ Stock Analysis page.